Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis‐related lung disease

Cystic fibrosis (CF) patients with advanced lung disease are at risk for developing pulmonary vascular disease and pulmonary hypertension, characterized by progressive exercise intolerance beyond the exercise‐limiting effects of airways disease in CF. We report on a patient with severe CF lung disease who experienced clinically significant improvements in exercise tolerance and pulmonary hypertension without changing lung function during sildenafil therapy. Pediatr Pulmonol. © 2006 Wiley‐Liss, Inc.

[1]  C M Harris,et al.  Sildenafil (Viagra) corrects ΔF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis , 2004, Thorax.

[2]  K. Broadley,et al.  Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease. , 2004, American journal of respiratory and critical care medicine.

[3]  S. Archer,et al.  Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension , 2003, Circulation.

[4]  W. Carroll,et al.  Sildenafil as a treatment for pulmonary hypertension , 2003, Archives of disease in childhood.

[5]  Webb Ak,et al.  The heart in cystic fibrosis. , 2002 .

[6]  N. Morrell,et al.  Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension , 2001, Circulation.

[7]  A. Magee,et al.  Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension , 2000, Heart.

[8]  P. Hanly,et al.  Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. , 1999, Chest.

[9]  G. Jackson,et al.  Effects of sildenafil citrate on human hemodynamics. , 1999, The American journal of cardiology.

[10]  A. Bossuyt,et al.  Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension , 1989, Pediatric pulmonology.

[11]  L. Reid,et al.  Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale. , 1985, The American review of respiratory disease.

[12]  T. Scanlin,et al.  Cardiac involvement in cystic fibrosis: early noninvasive detection and vasodilator therapy. , 1985, Pediatric pharmacology.

[13]  L. Reid,et al.  The pulmonary circulation in cystic fibrosis. , 1975, Thorax.

[14]  J. Vogel,et al.  The reversibility of pulmonary hypertension in patients with cystic fibrosis. Observations on the effects of tolazoline hydrochloride. , 1967, Pediatrics.

[15]  A. Fishman,et al.  PULMONARY HYPERTENSION AND COR PULMONALE IN CYSTIC FIBROSIS OF THE PANCREAS. , 1964, The Journal of pediatrics.